VBI Vaccines (VBIV)
NASDAQ:VBIV
Holding VBIV?
Track your performance easily

VBI Vaccines (VBIV) Financial Statements

2,222 Followers

VBI Vaccines Financial Overview

VBI Vaccines's market cap is currently ―. The company's EPS TTM is $-6.925; its P/E ratio is -0.11; VBI Vaccines is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 853.00K$ 6.62M$ 720.00K$ 485.00K$ 293.00K
Gross Profit$ -2.09M$ 4.10M$ 720.00K$ 485.00K$ 293.00K
EBIT$ 2.05M$ -18.39M$ -42.92M$ -26.32M$ -19.93M
EBITDA$ 2.53M$ -17.89M-$ -25.34M$ -22.46M
Net Income Common Stockholders$ -156.00K$ -21.31M$ -44.63M$ 12.24M$ -21.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.68M$ 35.45M$ 20.84M$ 40.39M$ 62.63M
Total Assets$ 86.95M$ 100.78M$ 88.32M$ 128.46M$ 155.09M
Total Debt$ 53.04M$ 52.72M$ 52.55M$ 52.37M$ 52.23M
Net Debt$ 29.36M$ 17.27M$ 31.71M$ 11.98M$ -10.40M
Total Liabilities$ 79.42M$ 80.90M$ 79.58M$ 83.44M$ 90.92M
Stockholders Equity$ 7.53M$ 19.89M$ 8.74M$ 45.02M$ 64.16M
Cash Flow-
Free Cash Flow$ -12.23M$ -8.07M-$ -21.86M$ -20.50M
Operating Cash Flow$ -12.06M$ -7.96M$ -19.21M$ -21.32M$ -19.05M
Investing Cash Flow$ -170.00K$ -113.00K$ -50.00K$ -534.00K$ -1.45M
Financing Cash Flow$ 272.00K$ 22.43M---
Currency in USD

VBI Vaccines Earnings and Revenue History

VBI Vaccines Debt to Assets

VBI Vaccines Cash Flow

VBI Vaccines Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis